Suppr超能文献

美国参与者中甲状腺功能障碍的流行趋势及其与死亡率的关联,1988-2012 年。

Trends in Prevalence of Thyroid Dysfunction and its Associations With Mortality Among US Participants, 1988-2012.

机构信息

Department of Endocrinology, Affiliated Drum Tower Hospital, Nanjing University School of Medicine, Nanjing 210008, China.

Endocrine and Metabolic Disease Medical Center, Affiliated Drum Tower Hospital, Nanjing University School of Medicine, Nanjing 210008, China.

出版信息

J Clin Endocrinol Metab. 2024 Jan 18;109(2):e657-e666. doi: 10.1210/clinem/dgad558.

Abstract

CONTEXT

Various dynamic factors could influence the prevalence and distribution of thyroid dysfunction.

OBJECTIVE

To provide national estimates and temporal trends in prevalence of thyroid dysfunction over the past 3 decades in United States and determine the impact of thyroid dysfunction on mortality in US adults.

METHODS

A cross-sectional analysis of data from 33 117 participants aged 12 years or older in the National Health and Nutrition Examination Survey III (1988-1994), 1999-2002, and 2007-2012.

RESULTS

The weighted mean age was 41.6 years, and 48.3% were men. In 2007 through 2012, the prevalence of subclinical and overt hypothyroidism, subclinical and overt hyperthyroidism was 4.3%, 0.33%, 3.2%, and 0.2% respectively. Eighty percent of individuals with thyroid dysfunction were previously undiagnosed. The prevalence of subclinical hypothyroidism and hyperthyroidism was stable, whereas overt hypothyroidism (0.54% [95% CI, 0.35-0.8] vs 0.33% [95% CI, 0.23-0.48]) and hyperthyroidism (0.8% [95% CI, 0.58-1.1] vs 0.2% [95% CI, 0.12-0.33]) were less prevalent in 2007-2012 compared to 1988-1994. Older age, White Americans, obesity, and positivity for thyroid peroxidase antibody and thyroglobulin antibody were risk factors for hypothyroidism, whereas older age, women, and Black Americans were risk factors for hyperthyroidism. Over a median follow-up of 17.2 years, no significant association was observed between any type of thyroid dysfunction with the risk of total or cardiovascular mortality. However, among individuals aged 65 years or older, subclinical hypothyroidism was associated with a higher risk of total mortality (hazard ratio, 1.17; 95% CI, 1.00-1.37; P = .05) and cardiovascular mortality (HR, 1.29; 95% CI, 1.04-1.62; P = .02).

CONCLUSIONS

The prevalence of subclinical thyroid dysfunction remained relatively unchanged, whereas that of overt thyroid dysfunction decreased. Subclinical hypothyroidism was associated with a higher mortality among individuals aged 65 years or older.

摘要

背景

各种动态因素可能会影响甲状腺功能障碍的流行和分布。

目的

提供过去 30 年来美国甲状腺功能障碍的患病率的国家估计值和时间趋势,并确定甲状腺功能障碍对美国成年人死亡率的影响。

方法

这是一项对 1988-1994 年、1999-2002 年和 2007-2012 年全国健康与营养调查 III 中 33117 名年龄在 12 岁及以上的参与者进行的横断面分析。

结果

加权平均年龄为 41.6 岁,48.3%为男性。2007 年至 2012 年,亚临床和显性甲状腺功能减退症、亚临床和显性甲状腺功能亢进症的患病率分别为 4.3%、0.33%、3.2%和 0.2%。80%的甲状腺功能障碍患者以前未被诊断。亚临床甲状腺功能减退症和甲状腺功能亢进症的患病率保持稳定,而显性甲状腺功能减退症(0.54%[95%CI,0.35-0.8] vs 0.33%[95%CI,0.23-0.48])和甲状腺功能亢进症(0.8%[95%CI,0.58-1.1] vs 0.2%[95%CI,0.12-0.33])的患病率在 2007-2012 年比 1988-1994 年更低。年龄较大、白种美国人、肥胖以及甲状腺过氧化物酶抗体和甲状腺球蛋白抗体阳性是甲状腺功能减退症的危险因素,而年龄较大、女性和黑种美国人是甲状腺功能亢进症的危险因素。在中位数为 17.2 年的中位随访期间,未观察到任何类型的甲状腺功能障碍与总死亡率或心血管死亡率之间存在显著关联。然而,在 65 岁或以上的人群中,亚临床甲状腺功能减退症与总死亡率(风险比,1.17;95%置信区间,1.00-1.37;P=0.05)和心血管死亡率(风险比,1.29;95%置信区间,1.04-1.62;P=0.02)的风险增加有关。

结论

亚临床甲状腺功能减退症的患病率保持相对不变,而显性甲状腺功能障碍的患病率下降。亚临床甲状腺功能减退症与 65 岁或以上人群的死亡率增加有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验